# A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

> **NCT01479621** · PHASE2 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 909 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fp MDPI
- **DRUG:** Flovent Diskus
- **DRUG:** albuterol/salbutamol
- **DRUG:** Placebo MDPI

## Key facts

- **NCT ID:** NCT01479621
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 909 (ACTUAL)
- **Last updated:** 2017-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479621, "A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01479621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*